JAZZ vs TASK
Jazz Pharmaceuticals PLC (JAZZ) versus Taskus Inc (TASK) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Taskus Inc (TASK) is a information technology services company listed on NASDAQ.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported TASK revenue for 2024-12-31 was $995.0M. Net income was $45.9M. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
Not investment advice. Open the JAZZ and TASK stock pages for the full models.
Not investment advice.